back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-12-10 13:56 Tx date 2025-12-08 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-93,103.20
-2,010 vol $46.32 each |
6,000 | |
| Filed 2025-12-10 13:55 Tx date 2025-12-08 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-402,103.80
-8,820 vol $45.59 each |
8,010 | |
| Filed 2025-12-10 13:55 Tx date 2025-12-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-647,306.25
-14,375 vol $45.03 each |
16,830 | |
| Filed 2025-12-04 13:07 Tx date 2025-11-28 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,365.97
-97 vol $45.01 each |
31,205 | |
| Filed 2025-10-02 17:14 Tx date 2025-10-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,004,000
-25,000 vol $40.16 each |
31,302 | |
| Filed 2025-10-02 13:36 Tx date 2025-10-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-25,000 vol |
1,805,000 | |
| Filed 2025-10-02 13:25 Tx date 2025-10-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$192,250
+25,000 vol $7.69 each |
56,302 | |
| Filed 2025-06-10 14:05 Tx date 2025-03-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+50,000 vol |
50,000 | |
| Filed 2025-06-10 14:03 Tx date 2014-11-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-03-14 13:07 Tx date 2025-03-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
||
| Filed 2025-03-14 13:07 Tx date 2025-03-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
1,880,000 | |
| Filed 2025-03-14 13:01 Tx date 2025-03-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+275,000 vol |
1,830,000 | |
| Filed 2025-01-28 12:32 Tx date 2025-01-27 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-16,315 vol |
1,555,000 | |
| Filed 2025-01-28 12:31 Tx date 2025-01-24 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-22,468 vol |
1,571,315 | |
| Filed 2025-01-28 12:29 Tx date 2025-01-23 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-16,217 vol |
1,593,783 | |
| Filed 2025-01-28 12:26 Tx date 2025-01-27 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-47,189.43
-1,149 vol $41.07 each |
31,302 | |
| Filed 2025-01-28 12:19 Tx date 2025-01-27 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$20,406
+1,149 vol $17.76 each |
32,451 | |
| Filed 2025-01-28 12:16 Tx date 2025-01-27 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-613,616.36
-15,166 vol $40.46 each |
31,302 | |
| Filed 2025-01-28 12:14 Tx date 2025-01-27 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$269,348
+15,166 vol $17.76 each |
46,468 | |
| Filed 2025-01-28 12:12 Tx date 2025-01-24 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-903,213.60
-22,468 vol $40.20 each |
31,302 |